If you are a female cancer survivor 21 years or older and live on Oahu, the University of Hawaii Cancer Center wants to hear from you.
Researchers are studying the impact of hula as a way to increase physical activity for female survivors of breast, cervical, endometrial, and ovarian cancers. The study will also look at how hula can affect a person’s quality of life.
“Research indicates that physical activity can improve cancer survival, as well as well‐being and quality of life. However, it can be difficult to maintain physical activity for cancer survivors. Hula is a culturally relevant form of physical activity that people enjoy and it requires participants to engage muscles throughout the body,” said Erin Bantum, Ph.D., associate researcher in the UH Cancer Center’s Cancer Prevention and Control Program.
This study builds on a pilot study that ran from November 2014 through November 2015, and was made possible by an anonymous donation exceeding $100,000. Researchers say it has the potential to impact many women in the community.
“As we analyze the data from our pilot study, we hope to understand more about the biological and psychosocial benefits that hula has had for our participants,” Bantum said. “One result that we were pleased with was the high rate of adherence to the hula program. Eighty percent of the participants completed the study with an average attendance of 83 percent.”
Researchers are currently recruiting participants for the study. The hula program for cancer survivors will be carried out for six months, twice per week, in addition to being asked to practice outside of class for one hour per week. Interested participants will have the option to join a daytime class at the UH Cancer Center or an early evening class at Pali Momi Medical Center.
Participants must meet the following requirements:
- Female breast, cervical, endometrial, or ovarian cancer survivor
- 21 years of age or older, resides on Oahu
- Completed primary treatment two months prior or longer
- Not currently receiving radiation or chemotherapy
For more information about the study call 441‐8190 or email firstname.lastname@example.org.